Adipose Tissue Insensitivity is the physiological state where fat cells fail to respond appropriately to key hormonal signals, such as insulin and catecholamines, which are crucial for regulating energy storage and release. This dysfunction compromises the adipocyte’s role in maintaining whole-body energy homeostasis, leading to a pathological shift in lipid metabolism. The condition often precedes or accompanies systemic metabolic disorders, including type 2 diabetes.
Origin
The term is descriptive, derived from the Latin adeps for fat and the clinical concept of biological insensitivity, which denotes a reduced responsiveness to stimuli. It originates from the core research of clinical endocrinology focused on the molecular pathology underlying obesity and insulin resistance. The understanding of this cellular failure is fundamental to modern metabolic medicine.
Mechanism
This insensitivity results from impaired receptor function or defects in the intracellular signaling cascades within the adipocyte, preventing the correct uptake of glucose or the regulated release of free fatty acids. Chronic low-grade inflammation within the fat tissue is a significant contributing factor, as inflammatory cytokines disrupt the delicate insulin and catecholamine signaling pathways. This dysregulation forces the liver and muscle to handle excess lipids, promoting ectopic fat deposition.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.